Jiangsu Bioperfectus Technologies Co., Ltd.

¥23.21As of Sun 8 Nov 2026, 12:00 UTC
SSE:688399Healthcare
Country China
PE (Fwd) •••
TSR 7Y CAGR 0.60%
Div yield —
ROE (0.86%)
Biotechnology
Beta (5Y) 0.87
PE TTM —
TSR TTM (55.44%)
Mkt cap ¥2.881B
ROIC (3.20%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥26
11.48%
(33.63%)
Hold 7|11|5|3|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.51
0.56
0.60
0.61
6.44%
8.58%
12.88%
19.27%
Revenue¥M
223.5
229.9
235.2
247.6
13.56%
11.67%
8.89%
10.91%
Peers (US$431.9M)
Cap (US$)
PE
440.2M
212.0x
Capital
TTM
5Y
10Y
Leveragex
0.162
(1.418)
(0.963)
EBIT/Intx
0.814
0.678
0.680
Own earn%
(104.66)
(74.52)
(67.09)
Sh yield%
54.41
21.48
18.88
Owners
Insiders/Inst%
4.57
80.45
Short interest%
5.60
SBC / revenue%
5.94
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
15–20
$1 testx
—
Incr. ROIC%
3